Interventional oncology
Localised, device-delivered therapy that concentrates treatment where tumours are addressed.
Specialty devices & pharmaceuticals
Where pharmaceuticals meet the devices left inside the body.
Angiotech Pharmaceuticals is a Canadian specialty medical device and pharmaceutical company focused on technologies for implantable medical devices, surgery, and targeted drug delivery. We became widely known for pioneering the combination of pharmaceuticals with medical devices — particularly through drug-coated stent technology.
Paclitaxel
Coated-device platform that defined drug elution
4
Therapeutic areas under active research
Vancouver
Headquarters, with a global remote team
Our research
Reducing the complications that follow an implant, an incision, or an injury.
Our research emphasises reducing complications associated with implanted medical devices, surgical procedures, and acute injuries by combining pharmaceuticals with innovative device designs. We develop technologies spanning interventional oncology, wound closure, ophthalmology, and the biomaterials used in medical implants.
Our most influential contribution is work on paclitaxel-coated medical devices, helping establish the concept of drug-eluting devices in cardiovascular medicine and influencing later generations of combination medical technologies.
Focus areas
Four fields where device design and drug delivery are inseparable.
Wound closure
Sutures, meshes and closure systems engineered to lower infection and healing complications.
Ophthalmology
Ocular delivery and implant technologies for sustained, precisely dosed treatment.
Biomaterials
Polymer and coating science that governs how implants behave in living tissue.
Voices from practice
What clinicians say about combination technology.
“Drug elution changed what we could promise a patient after an intervention. Angiotech's coating work sits behind that shift.”
“Fewer surgical-site complications means fewer readmissions. Combination closure technology is felt on the ward, not just in the lab.”
“The team starts from the complication rather than the compound. That discipline is why their programmes translate.”
Build combination technology with us.
Our remote positions are part of a strategy to build a talented, global team across the US, anchored to our Vancouver headquarters.